Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 462 entries
Sorted by: Best Match Show Resources per page
ECCO Essential Requirements for Quality Cancer Care: Colorectal Cancer. A critical review.

Critical reviews in oncology/hematology

Beets G, Sebag-Montefiore D, Andritsch E, Arnold D, Beishon M, Crul M, Dekker JW, Delgado Bolton R, Fléjou JF, Grisold W, Henning G, Laghi A, Lovey J, Negrouk A, Pereira P, Roca P, Saarto T, Seufferlein T, Taylor C, Ugolini G, Velde CV, Herck BV, Yared W, Costa A, Naredi P.
PMID: 28109408
Crit Rev Oncol Hematol. 2017 Feb;110:81-93. doi: 10.1016/j.critrevonc.2016.12.001. Epub 2016 Dec 08.

BACKGROUND: ECCO essential requirements for quality cancer care (ERQCC) are checklists and explanations of organisation and actions that are necessary to give high-quality care to patients who have a specific tumour type. They are written by European experts representing...

Cite
Beets G, Sebag-Montefiore D, Andritsch E, et al. ECCO Essential Requirements for Quality Cancer Care: Colorectal Cancer. A critical review. Crit Rev Oncol Hematol. 2016;110:81-93doi: 10.1016/j.critrevonc.2016.12.001.
Beets, G., Sebag-Montefiore, D., Andritsch, E., Arnold, D., Beishon, M., Crul, M., Dekker, J. W., Delgado Bolton, R., Fléjou, J. F., Grisold, W., Henning, G., Laghi, A., Lovey, J., Negrouk, A., Pereira, P., Roca, P., Saarto, T., Seufferlein, T., Taylor, C., Ugolini, G., Velde, C. V., Herck, B. V., Yared, W., Costa, A., & Naredi, P. (2017). ECCO Essential Requirements for Quality Cancer Care: Colorectal Cancer. A critical review. Critical reviews in oncology/hematology, 11081-93. https://doi.org/10.1016/j.critrevonc.2016.12.001
Beets, Geerard, et al. "ECCO Essential Requirements for Quality Cancer Care: Colorectal Cancer. A critical review." Critical reviews in oncology/hematology vol. 110 (2017): 81-93. doi: https://doi.org/10.1016/j.critrevonc.2016.12.001
Beets G, Sebag-Montefiore D, Andritsch E, Arnold D, Beishon M, Crul M, Dekker JW, Delgado Bolton R, Fléjou JF, Grisold W, Henning G, Laghi A, Lovey J, Negrouk A, Pereira P, Roca P, Saarto T, Seufferlein T, Taylor C, Ugolini G, Velde CV, Herck BV, Yared W, Costa A, Naredi P. ECCO Essential Requirements for Quality Cancer Care: Colorectal Cancer. A critical review. Crit Rev Oncol Hematol. 2017 Feb;110:81-93. doi: 10.1016/j.critrevonc.2016.12.001. Epub 2016 Dec 08. PMID: 28109408.
Copy Download .nbib Format: NLM
Techniques for health economics analysis in oncology: Part 1.

Critical reviews in oncology/hematology

Neymark N.
PMID: 10439049
Crit Rev Oncol Hematol. 1999 Mar;30(1):1-11. doi: 10.1016/s1040-8428(98)00026-2.

No abstract available.

Cite
Neymark N. Techniques for health economics analysis in oncology: Part 1. Crit Rev Oncol Hematol. 1999;30(1):1-11doi: 10.1016/s1040-8428(98)00026-2.
Neymark, N. (1999). Techniques for health economics analysis in oncology: Part 1. Critical reviews in oncology/hematology, 30(1), 1-11. https://doi.org/10.1016/s1040-8428(98)00026-2
Neymark, N. "Techniques for health economics analysis in oncology: Part 1." Critical reviews in oncology/hematology vol. 30,1 (1999): 1-11. doi: https://doi.org/10.1016/s1040-8428(98)00026-2
Neymark N. Techniques for health economics analysis in oncology: Part 1. Crit Rev Oncol Hematol. 1999 Mar;30(1):1-11. doi: 10.1016/s1040-8428(98)00026-2. PMID: 10439049.
Copy Download .nbib Format: NLM
Response assessment using radiological methods.

Critical reviews in oncology/hematology

Gwyther SJ.
PMID: 10439053
Crit Rev Oncol Hematol. 1999 Mar;30(1):45-62. doi: 10.1016/s1040-8428(98)00025-0.

No abstract available.

Cite
Gwyther SJ. Response assessment using radiological methods. Crit Rev Oncol Hematol. 1999;30(1):45-62doi: 10.1016/s1040-8428(98)00025-0.
Gwyther, S. J. (1999). Response assessment using radiological methods. Critical reviews in oncology/hematology, 30(1), 45-62. https://doi.org/10.1016/s1040-8428(98)00025-0
Gwyther, S J. "Response assessment using radiological methods." Critical reviews in oncology/hematology vol. 30,1 (1999): 45-62. doi: https://doi.org/10.1016/s1040-8428(98)00025-0
Gwyther SJ. Response assessment using radiological methods. Crit Rev Oncol Hematol. 1999 Mar;30(1):45-62. doi: 10.1016/s1040-8428(98)00025-0. PMID: 10439053.
Copy Download .nbib Format: NLM
Medical communications: techniques and strategies.

Critical reviews in oncology/hematology

Coram GJ.
PMID: 10439056
Crit Rev Oncol Hematol. 1999 Mar;30(1):81-8. doi: 10.1016/s1040-8428(98)00035-3.

No abstract available.

Cite
Coram GJ. Medical communications: techniques and strategies. Crit Rev Oncol Hematol. 1999;30(1):81-8doi: 10.1016/s1040-8428(98)00035-3.
Coram, G. J. (1999). Medical communications: techniques and strategies. Critical reviews in oncology/hematology, 30(1), 81-8. https://doi.org/10.1016/s1040-8428(98)00035-3
Coram, G J. "Medical communications: techniques and strategies." Critical reviews in oncology/hematology vol. 30,1 (1999): 81-8. doi: https://doi.org/10.1016/s1040-8428(98)00035-3
Coram GJ. Medical communications: techniques and strategies. Crit Rev Oncol Hematol. 1999 Mar;30(1):81-8. doi: 10.1016/s1040-8428(98)00035-3. PMID: 10439056.
Copy Download .nbib Format: NLM
WITHDRAWN: Cognitive effects of androgen deprivation therapy in an older cohort of men with prostrate cancer.

Critical reviews in oncology/hematology

Mohile SG, Lacy M, Rodin M, Bylow K, Dale W, Meager MR, Stadler WM.
PMID: 20427196
Crit Rev Oncol Hematol. 2010 Jul 01; doi: 10.1016/j.critrevonc.2009.04.001. Epub 2010 Jul 01.

This article has been withdrawn from Critical Reviews in Oncology/Hematology. With the permission of the authors, it has been published in Volume1, issue 1 of the Journal of Geriatric Oncology (www.geriatriconcology.net). The full Elsevier Policy on Article Withdrawal can...

Cite
Mohile SG, Lacy M, Rodin M, et al. WITHDRAWN: Cognitive effects of androgen deprivation therapy in an older cohort of men with prostrate cancer. Crit Rev Oncol Hematol. 2010;doi: 10.1016/j.critrevonc.2009.04.001.
Mohile, S. G., Lacy, M., Rodin, M., Bylow, K., Dale, W., Meager, M. R., & Stadler, W. M. (2010). WITHDRAWN: Cognitive effects of androgen deprivation therapy in an older cohort of men with prostrate cancer. Critical reviews in oncology/hematology, . https://doi.org/10.1016/j.critrevonc.2009.04.001
Mohile, Supriya Gupta, et al. "WITHDRAWN: Cognitive effects of androgen deprivation therapy in an older cohort of men with prostrate cancer." Critical reviews in oncology/hematology vol. (2010). doi: https://doi.org/10.1016/j.critrevonc.2009.04.001
Mohile SG, Lacy M, Rodin M, Bylow K, Dale W, Meager MR, Stadler WM. WITHDRAWN: Cognitive effects of androgen deprivation therapy in an older cohort of men with prostrate cancer. Crit Rev Oncol Hematol. 2010 Jul 01; doi: 10.1016/j.critrevonc.2009.04.001. Epub 2010 Jul 01. PMID: 20427196.
Copy Download .nbib Format: NLM
Cardiac side effects of molecular targeted therapies: towards a better dialogue between oncologists and cardiologists.

Critical reviews in oncology/hematology

Ederhy S, Izzedine H, Massard C, Dufaitre G, Spano JP, Milano G, Meuleman C, Besse B, Boccara F, Kahyat D, Cohen A, Soria JC.
PMID: 21330149
Crit Rev Oncol Hematol. 2011 Dec;80(3):369-79. doi: 10.1016/j.critrevonc.2011.01.009. Epub 2011 Feb 16.

Molecular targeted therapies (MTTs) have become a major component of modern management of various hematological and solid malignancies. However, some MTTs have been associated with cardiotoxicity. MTT-induced cardiovascular side effects include left ventricular systolic dysfunction, heart failure, conduction abnormalities,...

Cite
Ederhy S, Izzedine H, Massard C, et al. Cardiac side effects of molecular targeted therapies: towards a better dialogue between oncologists and cardiologists. Crit Rev Oncol Hematol. 2011;80(3):369-79doi: 10.1016/j.critrevonc.2011.01.009.
Ederhy, S., Izzedine, H., Massard, C., Dufaitre, G., Spano, J. P., Milano, G., Meuleman, C., Besse, B., Boccara, F., Kahyat, D., Cohen, A., & Soria, J. C. (2011). Cardiac side effects of molecular targeted therapies: towards a better dialogue between oncologists and cardiologists. Critical reviews in oncology/hematology, 80(3), 369-79. https://doi.org/10.1016/j.critrevonc.2011.01.009
Ederhy, Stephane, et al. "Cardiac side effects of molecular targeted therapies: towards a better dialogue between oncologists and cardiologists." Critical reviews in oncology/hematology vol. 80,3 (2011): 369-79. doi: https://doi.org/10.1016/j.critrevonc.2011.01.009
Ederhy S, Izzedine H, Massard C, Dufaitre G, Spano JP, Milano G, Meuleman C, Besse B, Boccara F, Kahyat D, Cohen A, Soria JC. Cardiac side effects of molecular targeted therapies: towards a better dialogue between oncologists and cardiologists. Crit Rev Oncol Hematol. 2011 Dec;80(3):369-79. doi: 10.1016/j.critrevonc.2011.01.009. Epub 2011 Feb 16. PMID: 21330149.
Copy Download .nbib Format: NLM
Continuity and diversity.

Critical reviews in oncology/hematology

Aapro M.
PMID: 29242024
Crit Rev Oncol Hematol. 2018 Jan;121:A2. doi: 10.1016/j.critrevonc.2017.12.001. Epub 2017 Dec 07.

No abstract available.

Cite
Aapro M. Continuity and diversity. Crit Rev Oncol Hematol. 2017;121:A2doi: 10.1016/j.critrevonc.2017.12.001.
Aapro, M. (2018). Continuity and diversity. Critical reviews in oncology/hematology, 121A2. https://doi.org/10.1016/j.critrevonc.2017.12.001
Aapro, Matti. "Continuity and diversity." Critical reviews in oncology/hematology vol. 121 (2018): A2. doi: https://doi.org/10.1016/j.critrevonc.2017.12.001
Aapro M. Continuity and diversity. Crit Rev Oncol Hematol. 2018 Jan;121:A2. doi: 10.1016/j.critrevonc.2017.12.001. Epub 2017 Dec 07. PMID: 29242024.
Copy Download .nbib Format: NLM
Radiological evaluation of response to immunotherapy in brain tumors: Where are we now and where are we going?.

Critical reviews in oncology/hematology

Porcu M, Solinas C, Garofalo P, de Azambuja E, Scartozzi M, Willard-Gallo K, Preusser M, Saba L.
PMID: 29759556
Crit Rev Oncol Hematol. 2018 Jun;126:135-144. doi: 10.1016/j.critrevonc.2018.03.026. Epub 2018 Apr 07.

No abstract available.

Cite
Porcu M, Solinas C, Garofalo P, et al. Radiological evaluation of response to immunotherapy in brain tumors: Where are we now and where are we going?. Crit Rev Oncol Hematol. 2018;126:135-144doi: 10.1016/j.critrevonc.2018.03.026.
Porcu, M., Solinas, C., Garofalo, P., de Azambuja, E., Scartozzi, M., Willard-Gallo, K., Preusser, M., & Saba, L. (2018). Radiological evaluation of response to immunotherapy in brain tumors: Where are we now and where are we going?. Critical reviews in oncology/hematology, 126135-144. https://doi.org/10.1016/j.critrevonc.2018.03.026
Porcu, Michele, et al. "Radiological evaluation of response to immunotherapy in brain tumors: Where are we now and where are we going?." Critical reviews in oncology/hematology vol. 126 (2018): 135-144. doi: https://doi.org/10.1016/j.critrevonc.2018.03.026
Porcu M, Solinas C, Garofalo P, de Azambuja E, Scartozzi M, Willard-Gallo K, Preusser M, Saba L. Radiological evaluation of response to immunotherapy in brain tumors: Where are we now and where are we going?. Crit Rev Oncol Hematol. 2018 Jun;126:135-144. doi: 10.1016/j.critrevonc.2018.03.026. Epub 2018 Apr 07. PMID: 29759556.
Copy Download .nbib Format: NLM
Corrigendum to "Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer" [Crit. Rev. Oncol. Hematol. 137, May (2019) 57-83].

Critical reviews in oncology/hematology

Gonzalez-Avila G, Sommer B, Mendoza-Posada DA, Ramos C, Garcia-Hernandez AA, Falfan-Valencia R.
PMID: 31092373
Crit Rev Oncol Hematol. 2019 Jun;138:172. doi: 10.1016/j.critrevonc.2019.04.017. Epub 2019 Apr 23.

No abstract available.

Cite
Gonzalez-Avila G, Sommer B, Mendoza-Posada DA, et al. Corrigendum to "Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer" [Crit. Rev. Oncol. Hematol. 137, May (2019) 57-83]. Crit Rev Oncol Hematol. 2019;138:172doi: 10.1016/j.critrevonc.2019.04.017.
Gonzalez-Avila, G., Sommer, B., Mendoza-Posada, D. A., Ramos, C., Garcia-Hernandez, A. A., & Falfan-Valencia, R. (2019). Corrigendum to "Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer" [Crit. Rev. Oncol. Hematol. 137, May (2019) 57-83]. Critical reviews in oncology/hematology, 138172. https://doi.org/10.1016/j.critrevonc.2019.04.017
Gonzalez-Avila, Georgina, et al. "Corrigendum to "Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer" [Crit. Rev. Oncol. Hematol. 137, May (2019) 57-83]." Critical reviews in oncology/hematology vol. 138 (2019): 172. doi: https://doi.org/10.1016/j.critrevonc.2019.04.017
Gonzalez-Avila G, Sommer B, Mendoza-Posada DA, Ramos C, Garcia-Hernandez AA, Falfan-Valencia R. Corrigendum to "Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer" [Crit. Rev. Oncol. Hematol. 137, May (2019) 57-83]. Crit Rev Oncol Hematol. 2019 Jun;138:172. doi: 10.1016/j.critrevonc.2019.04.017. Epub 2019 Apr 23. PMID: 31092373.
Copy Download .nbib Format: NLM
Tumor microbiome: Pancreatic cancer and duodenal fluids contain multitudes, …but do they contradict themselves?.

Critical reviews in oncology/hematology

Meijer LL, Zwart ES, Brandt BW, Mebius R, Deng D, Giovannetti E, Zaura E, Kazemier G.
PMID: 31731215
Crit Rev Oncol Hematol. 2019 Dec;144:102824. doi: 10.1016/j.critrevonc.2019.102824. Epub 2019 Nov 02.

No abstract available.

Cite
Meijer LL, Zwart ES, Brandt BW, et al. Tumor microbiome: Pancreatic cancer and duodenal fluids contain multitudes, …but do they contradict themselves?. Crit Rev Oncol Hematol. 2019;144:102824doi: 10.1016/j.critrevonc.2019.102824.
Meijer, L. L., Zwart, E. S., Brandt, B. W., Mebius, R., Deng, D., Giovannetti, E., Zaura, E., & Kazemier, G. (2019). Tumor microbiome: Pancreatic cancer and duodenal fluids contain multitudes, …but do they contradict themselves?. Critical reviews in oncology/hematology, 144102824. https://doi.org/10.1016/j.critrevonc.2019.102824
Meijer, Laura L, et al. "Tumor microbiome: Pancreatic cancer and duodenal fluids contain multitudes, …but do they contradict themselves?." Critical reviews in oncology/hematology vol. 144 (2019): 102824. doi: https://doi.org/10.1016/j.critrevonc.2019.102824
Meijer LL, Zwart ES, Brandt BW, Mebius R, Deng D, Giovannetti E, Zaura E, Kazemier G. Tumor microbiome: Pancreatic cancer and duodenal fluids contain multitudes, …but do they contradict themselves?. Crit Rev Oncol Hematol. 2019 Dec;144:102824. doi: 10.1016/j.critrevonc.2019.102824. Epub 2019 Nov 02. PMID: 31731215.
Copy Download .nbib Format: NLM
Hadrontherapy techniques for breast cancer.

Critical reviews in oncology/hematology

Loap P, De Marzi L, Almeida CE, Barcellini A, Bradley J, de Santis MC, Dendale R, Jimenez R, Orlandi E, Kirova Y.
PMID: 34958916
Crit Rev Oncol Hematol. 2021 Dec 24;169:103574. doi: 10.1016/j.critrevonc.2021.103574. Epub 2021 Dec 24.

Radiotherapy plays a key role in breast cancer treatment, and recent technical advances have been made to improve the therapeutic window by limiting the risk of radiation-induced toxicity or by increasing tumor control. Hadrontherapy is a form a radiotherapy...

Cite
Loap P, De Marzi L, Almeida CE, et al. Hadrontherapy techniques for breast cancer. Crit Rev Oncol Hematol. 2021;169:103574doi: 10.1016/j.critrevonc.2021.103574.
Loap, P., De Marzi, L., Almeida, C. E., Barcellini, A., Bradley, J., de Santis, M. C., Dendale, R., Jimenez, R., Orlandi, E., & Kirova, Y. (2021). Hadrontherapy techniques for breast cancer. Critical reviews in oncology/hematology, 169103574. https://doi.org/10.1016/j.critrevonc.2021.103574
Loap, Pierre, et al. "Hadrontherapy techniques for breast cancer." Critical reviews in oncology/hematology vol. 169 (2021): 103574. doi: https://doi.org/10.1016/j.critrevonc.2021.103574
Loap P, De Marzi L, Almeida CE, Barcellini A, Bradley J, de Santis MC, Dendale R, Jimenez R, Orlandi E, Kirova Y. Hadrontherapy techniques for breast cancer. Crit Rev Oncol Hematol. 2021 Dec 24;169:103574. doi: 10.1016/j.critrevonc.2021.103574. Epub 2021 Dec 24. PMID: 34958916.
Copy Download .nbib Format: NLM
An analysis of the evidence underpinning the national comprehensive cancer network practice guidelines.

Critical reviews in oncology/hematology

Love M, Staggs J, Walters C, Wayant C, Torgerson T, Hartwell M, Anderson JM, Lillie A, Myers K, Brachtenbach T, Derby M, Vassar M.
PMID: 34838981
Crit Rev Oncol Hematol. 2021 Nov 25;169:103549. doi: 10.1016/j.critrevonc.2021.103549. Epub 2021 Nov 25.

OBJECTIVE: This study assesses the quality and completeness of systematic reviews (SRs) included by the National Comprehensive Cancer Network (NCCN) cancer screening clinical practice guidelines (CPGs).METHODS: We evaluated SRs according to PRISMA (Preferred Reporting Items for Systematic Reviews and...

Cite
Love M, Staggs J, Walters C, et al. An analysis of the evidence underpinning the national comprehensive cancer network practice guidelines. Crit Rev Oncol Hematol. 2021;169:103549doi: 10.1016/j.critrevonc.2021.103549.
Love, M., Staggs, J., Walters, C., Wayant, C., Torgerson, T., Hartwell, M., Anderson, J. M., Lillie, A., Myers, K., Brachtenbach, T., Derby, M., & Vassar, M. (2021). An analysis of the evidence underpinning the national comprehensive cancer network practice guidelines. Critical reviews in oncology/hematology, 169103549. https://doi.org/10.1016/j.critrevonc.2021.103549
Love, Mitchell, et al. "An analysis of the evidence underpinning the national comprehensive cancer network practice guidelines." Critical reviews in oncology/hematology vol. 169 (2021): 103549. doi: https://doi.org/10.1016/j.critrevonc.2021.103549
Love M, Staggs J, Walters C, Wayant C, Torgerson T, Hartwell M, Anderson JM, Lillie A, Myers K, Brachtenbach T, Derby M, Vassar M. An analysis of the evidence underpinning the national comprehensive cancer network practice guidelines. Crit Rev Oncol Hematol. 2021 Nov 25;169:103549. doi: 10.1016/j.critrevonc.2021.103549. Epub 2021 Nov 25. PMID: 34838981.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 462 entries